Table 3 Univariate Analysis of Proportional Hazards Regression to Death, Cholangiocarcinoma or Liver Transplant
Characteristic | Hazard ratio (HR) | 95% HR confidence interval | P-value |
|---|---|---|---|
Gender | 1.065 | (0.515, 2.200) | 0.87 |
Race | 0.835 | (0.3, 2.327) | 0.73 |
   White |  |  |  |
   Non-white |  |  |  |
Age at diagnosis | 1.029 | (1.004, 1.054) | 0.02 |
IBD | 0.657 | (0.315, 1.373) | 0.26 |
   No |  |  |  |
   Yes |  |  |  |
Lab measurement at study entry | Â | Â | Â |
   Sodium | 1.144 | (1.022, 1.28) | 0.02 |
   Creatinine | 4.034 | (1.116, 14.584) | 0.03 |
   Alkaline phosphatase | 1.000 | (0.999, 1.002) | 0.47 |
   Alanine aminotransferase | 0.997 | (0.993, 1.001) | 0.14 |
   Aspartate aminotransferase | 0.996 | (0.992, 1.001) | 0.13 |
   Bilirubin | 1.122 | (1.039, 1.211) | 0.003 |
   INR | 1.569 | (0.874, 2.818) | 0.13 |
   Albumin | 1.013 | (0.938, 1.095) | 0.74 |
   MELD | 1.066 | (0.998, 1.139) | 0.06 |
Lab measurement at last entry | Â | Â | Â |
   Sodium | 0.941 | (0.804, 1.101) | 0.45 |
   Creatinine | 1.873 | (0.711, 4.932) | 0.20 |
   Alkaline phosphatase | 1.001 | (0.999, 1.003) | 0.51 |
   Alanine aminotransferase | 0.999 | (0.992, 1.006) | 0.76 |
   Aspartate aminotransferase | 1.000 | (0.994, 1.006) | 0.99 |
   Bilirubin | 1.09 | (0.982, 1.210) | 0.11 |
   International normalized ratio | 1.335 | (0.440, 4.045) | 0.61 |
   Albumin | 0.329 | (0.153, 0.709) | 0.005 |